secwatch.observer — SEC 8-K summary
======================================

Issuer:     TriSalus Life Sciences, Inc. (TLSI)
CIK:        0001826667
Form:       8-K
Filed at:   2022-02-23T23:59:59+00:00
Accession:  0001104659-22-026153
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Maurice Ferré resigns from MedTech board; Aguero appointed to committees
--------------------------------------------------------------------------------

- Maurice R. Ferré resigned as director and all positions on Feb 19, 2022; no disagreement with the company.
- Manuel Aguero appointed to the Audit and Compensation committees effective upon Ferré's resignation.
- Ferré remains Chairman of Memic Innovative Surgery, the target in MedTech's proposed business combination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826667/000110465922026153/0001104659-22-026153-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826667/000110465922026153/tm227498d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-026153

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer